Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NIMA-related kinase 1 (NEK1) is a multifunctional serine/threonine and tyrosine kinase that serves as a critical regulator of the cell cycle, DNA damage response (DDR), and ciliary function. It is localized to the centrosome, nucleus, and primary cilium, where it coordinates microtubule stability and nucleocytoplasmic transport. Mutations in the NEK1 gene are strongly associated with several human pathologies, most notably amyotrophic lateral sclerosis (ALS), where it is one of the most common genetic risk factors, accounting for 2-3% of cases. In ALS, loss-of-function variants lead to impaired microtubule homeostasis and the formation of toxic protein aggregates. NEK1 is also implicated in polycystic kidney disease (PKD) and various malignancies, where its role in DNA repair makes it a potential target for sensitizing tumors to radiotherapy or chemotherapy. Current drug discovery efforts focus on small-molecule inhibitors like BSc5367 for cancer research and strategies to stabilize microtubules in neurodegenerative contexts.
ATP-competitive inhibition of the kinase domain to block phosphorylation of substrates involved in DNA repair and microtubule stability.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NIMA-related kinase 1 (NEK1) (NEK1).